In 2020, I have obtained a Master’s degree in Medical Biotechnology at Wageningen University and Research in The Netherlands. During my studies there, I have worked in a laboratory of applied microbiology which is led by John Van Der Oost, who is a renowned scientist known as one of the pioneers of Crispr-Cas9. My master’s thesis project in this group was aimed at developing a novel, homology based, DNA cloning method.
After finishing my thesis project I moved to Switzerland, where I completed an internship in a Biotech company called ‘’Amal Therapeutics’’. The goal of this company is to develop therapeutic vaccines against cancer. During my internship at ‘’Amal therapeutics’’, I have worked in an in vitro department, where I developed and implemented a vaccine potency evaluation protocol on a newly adopted cell line.
Soon after, I returned to Lithuania and started working for “ThermoFisher Scientific” as a junior Scientist. While working at this position, I was involved in qPCR and Digital PCR product development and release. In the end of 2021, I joined VU GMC-EMBL PI. Currently, I’m working on a project which explores the relationship between CRISPR-Cas adaptation and genome-wide methylation patterns.